|
Salesforce India has announced the availability of Agentforce Life Sciences for customer engagement, extending the Agentforce Life Sciences portfolio with a new agent-first solution that revolutionizes the way life sciences companies interact with healthcare professionals (HCPs).
The new module aims to solve a critical industry challenge. Burnt-out physicians have 75% more information per drug to parse through than a decade ago, but barely a third of healthcare professionals feel their needs are being met and continue to cite feeling spammed by pharmaceutical and medical device organizations. Amid rising scrutiny and pipeline pressures, Agentforce Life Sciences employs digital labour to cut through the noise, drive meaningful engagement, and help close care gaps.
Agentforce Life Sciences helps reimagine how drugs and devices are discovered, approved, accessed, and administered, allowing people to focus on the human aspects of healthcare.
Built natively on Salesforce’s platform, Agentforce Life Sciences for customer engagement goes beyond traditional CRM and delivers a consumer-grade, conversational user experience with enterprise-grade security directly in the flow of work, so reps can make the most of their limited time with overwhelmed practitioners. And with audio-dictated notes, advocacy scoring, radio-like spotlights, and concise account summaries, on-the-go reps can unlock 24/7 access to vital information to help Life Sciences best treat their patients.
Mankiran Chowhan, managing director - sales at Salesforce India said, “India’s life sciences sector is scaling at an incredible pace, in parallel, the engagement model with doctors needs to keep pace. With Agentforce Life Sciences, we’re fundamentally upgrading that model. We're moving from high-volume, low-impact communication to intelligent, trusted collaboration. This allows companies to serve the immense Indian market more effectively and helps empower healthcare professionals to make faster, better-informed decisions for their patients. For doctors, it means getting the right insights to better treat their patients. And for India, it means closing the gap between medical innovation and patient access."
B. Murali Krishna Reddy, director - India and Emerging Markets, Hetero said, "As one of India’s leading life sciences companies, we at Hetero believe that scale and trust are the cornerstones of our success. Agentforce Life Sciences provides the robust digital foundation we need to engage responsibly with our global customers and build enduring relationships. With Salesforce, we are embracing a future where AI enhances every interaction, enabling us to efficiently manage pipelines and orders while eliminating complexities in working across multiple products and geographies."
|